Rockwell Medical Inc.
RMTI | NASDAQ
$8.69
-$0.01 (-0.11%)
Sep 22, 2026, 2:14 PM ET · Market open
Market Data
Market Cap $34.34M
Enterprise Value $24.26M
Beta 1.64
Average Volume 33.21K
Shares Outstanding (Diluted) 3.96M
Shares Change YoY 15.37%
Institutional Ownership 10.09%
Exchange NASDAQ
ISIN US7743744093
Price Performance
Price Change 1M 13.8%
Price Change 3M 33.2%
Price Change 6M -14.4%
Price Change YTD 3.1%
Price Change 1Y -32.1%
Price Change 3Y -53.2%
Price Change 5Y -87.5%
1M CAGR (ann.) 21.9%
1Y CAGR (ann.) -34.6%
5Y CAGR (ann.) -33.8%
All-Time CAGR -20.3%
Valuation
PE Ratio -6.40
Forward PE N/A
PEG Ratio 0.03
Forward PEG 0.08
PS Ratio 0.51
Forward PS 0.40
PB Ratio 1.00
P/FCF Ratio 22.81
P/Adj. FCF Ratio -106.13
P/OCF Ratio 12.19
EV/Sales 0.35
EV/EBIT -6.14
EV/EBITDA -10.37
EV/FCF 15.76
Earnings Yield -15.6%
FCF Yield 4.4%
Adj. FCF Yield -0.9%
Financial Health
Net Cash $15.79M
Total Debt $13.93M
Cash & Short-Term Investments $24.8M
Total Assets $56.53M
Current Ratio 3.25
Quick Ratio 3.00
Debt / Equity Ratio 0.40
Debt / EBITDA -5.95
Debt / FCF 9.05
OCF / Debt 0.21
Interest Coverage -3.99
Altman Z-Score -7.56
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 17.7%
Operating Profit Margin -6.5%
EBITDA Margin -3.4%
Net Profit Margin -7.3%
FCF Margin 2.2%
Adj. FCF Margin -0.5%
SBC / Revenue 2.7%
SBC Impact (per share) -121.5%
Returns
Return on Assets -9.0%
Return on Equity -14.0%
Return on Invested Capital -9.2%
Return on Capital Employed -10.0%
Return on Tangible Assets -11.0%
Historical Growth (CAGR)
Revenue CAGR 3Y -2.9%
Revenue CAGR 5Y 2.6%
Revenue CAGR 10Y 2.2%
EPS CAGR 3Y 13.0%
EPS CAGR 5Y 78.6%
EPS CAGR 10Y 25.1%
FCF CAGR 3Y 1019.8%
FCF CAGR 5Y 95.2%
FCF CAGR 10Y 18.7%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 16
EPS Growth Next 3Y 66.9%
Revenue Growth Next 3Y 5.5%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.13
EPS Growth Est (next Q) -74.0%
Revenue Est (next Q) $18.22M
Revenue Growth Est (next Q) 14.4%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $20
Price Target Upside 124.7%
Cash Flow
Operating Cash Flow $2.9M
Free Cash Flow $1.54M
Adj. Free Cash Flow $-331K
FCF Per Share $0.39
OCF Per Share $0.73
OCF/S Ratio 4.2%
Income Statement
Revenue $69.39M
Gross Profit $12.29M
Operating Income $-4.52M
EBITDA $-2.34M
Net Income $-5.08M
EPS (Diluted) -$1.39
Revenue / Employee $441.97K
Profit / Employee $-32.38K
Employees 157
Add to Watchlist
Select watchlists to add or remove RMTI